Events

Webinar: Tasly Pharmaceuticals and Mauna Kea Technologies Joint Venture

July 11, 2022

The Company’s management shared more information about the Tasly Pharmaceuticals and Mauna Kea Technologies Joint Venture: 

Latest News

Mauna Kea Technologies Announces Major Milestone for Cellvizio® in Pancreatic Cysts with CLIMB Study Selected for ASGE Presidential Plenary Session at DDW 2026 

Mauna Kea Technologies Announces Major Milestone for Cellvizio® in Pancreatic Cysts with CLIMB Study Selected for ASGE Presidential Plenary Session at DDW 2026 

Mauna Kea Technologies Accelerates International Expansion with New Regulatory Clearances in Switzerland and the United Kingdom 

Mauna Kea Technologies Accelerates International Expansion with New Regulatory Clearances in Switzerland and the United Kingdom 

Mauna Kea Technologies Announces CE MDR Certification For Cellvizio® and Its Associated Probes

Mauna Kea Technologies Announces CE MDR Certification For Cellvizio® and Its Associated Probes

No results found.